\
&
Contact us
\
&
Contact us
Published on | 4 months ago
Programmes Digital Europe Advanced Digital SkillsThe European Skills Agenda is a five-year plan to help individuals and businesses develop more and better skills, and to put them to use. It builds on actions set in the EU Skills Agenda (2016) and is linked to the Digital Decade Policy Programme 2030, and to the European Industrial Strategy when it comes to the availability of digital skills for the EU industry, mainly SMEs. The European Skills Agenda is formed of four building blocks (join forces, right skills for jobs, tools to support people in live long learning and unlock investments in skills) covering twelve specific actions.
Knowledge of underlying EU policies and legislations is a key element in Digital Europe proposals as they play an important role in the “relevance” evaluation criterion. This Policy Briefing is one of several briefings prepared by DEP4ALL, the NCP Network for the Digital Europe programme, to support applicants with summaries of relevant EU initiatives.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
